3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Head and Neck Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Radiation Injuries
2
Xerostomia
1
Uterine Cervical Neoplasms
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Salivary Gland Neoplasms
1
Prostatic Neoplasms
1
Multiple Myeloma
1
Mucositis
1
Deglutition Disorders
1
Colorectal Neoplasms
1
Brain Neoplasms
1
Interventions
Ifosfamide
6
X-Rays
5
Phantoms, Imaging
5
Magnetic Resonance Spectroscopy
5
Filgrastim
5
Etoposide
5
Doxorubicin
5
Cyclophosphamide
5
Vincristine
4
Temozolomide
4
Specimen Handling
4
Radiotherapy
4
Nuclear Medicine Department, Hospital
4
Melphalan
4
Thiotepa
3
Irinotecan
3
Biopsy
3
Bevacizumab
3
ulixertinib
2
trioctyl phosphine oxide
2
tipifarnib
2
temsirolimus
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Neuroectodermal Tumors, Primitive, Peripheral
×
Amifostine
×
Clear all
No trials found.